Literature DB >> 25901138

Neutrophilic-chronic myeloid leukemia: A case report.

Nahlah S Al Ghasham1.   

Abstract

Neutrophilic-chronic myelogenous leukemia (CML-N) is a rare chronic myelogenous leukemia (CML) variant characterized by BCR-ABL1 positive chronic neutrophilia. It has a BCR breakpoint on chromosome 22 between exons 17 and 20 in a region designated as micro-BCR. It is thought to have a more benign course than classical CML. This case report describes a 41-year-old Saudi woman diagnosed with CML-N. The peripheral blood and bone marrow picture for her were dominated by segmented neutrophils and fluorescent in situ hybridization was positive for BCR/ABL fusion of t(9;22). Our patient eventually required a stem cell transplant because of imatinib intolerance and bone marrow failure believed to be induced by nilotinib.

Entities:  

Keywords:  Chronic myeloid leukemia (CML); Neutrophilia; Neutrophilic-chronic myeloid leukemia (CML-N)

Year:  2015        PMID: 25901138      PMCID: PMC4394944     

Source DB:  PubMed          Journal:  Int J Health Sci (Qassim)        ISSN: 1658-3639


  5 in total

1.  The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype.

Authors:  J V Melo
Journal:  Blood       Date:  1996-10-01       Impact factor: 22.113

2.  Neutrophilic-chronic myeloid leukemia: a distinct disease with a specific molecular marker (BCR/ABL with C3/A2 junction)

Authors:  F Pane; F Frigeri; M Sindona; L Luciano; F Ferrara; R Cimino; G Meloni; G Saglio; F Salvatore; B Rotoli
Journal:  Blood       Date:  1996-10-01       Impact factor: 22.113

3.  New type of Bcr/Abl junction in Philadelphia chromosome-positive chronic myelogenous leukemia.

Authors:  G Saglio; A Guerrasio; C Rosso; A Zaccaria; A Tassinari; A Serra; G Rege-Cambrin; U Mazza; F Gavosto
Journal:  Blood       Date:  1990-11-01       Impact factor: 22.113

4.  Chronic neutrophilic leukemia. Report of two cases and review of the literature.

Authors:  W You; I M Weisbrot
Journal:  Am J Clin Pathol       Date:  1979-08       Impact factor: 2.493

5.  Neutrophilic-chronic myeloid leukemia: low levels of p230 BCR/ABL mRNA and undetectable BCR/ABL protein may predict an indolent course.

Authors:  Srdan Verstovsek; Hui Lin; Hagop Kantarjian; Giuseppe Saglio; Daniela De Micheli; Fabrizio Pane; Guillermo Garcia-Manero; Mariano Intrieri; Bruno Rotoli; Francesco Salvatore; Jie Q Guo; Moshe Talpaz; Giorgina Specchia; Gianni Pizzolo; Anna Marina Liberati; Jorge Cortes; Robert C Quackenbush; Ralph B Arlinghaus
Journal:  Cancer       Date:  2002-05-01       Impact factor: 6.860

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.